HIV-1 Capsid Inhibitors: A Sword to Destroy the Virus

衣壳 病毒学 人类免疫缺陷病毒(HIV) 病毒 生物 化学 计算机科学 操作系统
作者
Xujie Zhang,Shujing Xu,Lin Sun,Dang Ding,Yucen Tao,Dongwei Kang,Xinyong Liu,Peng Zhan
出处
期刊:Future Medicinal Chemistry [Newlands Press Ltd]
卷期号:14 (9): 605-607 被引量:12
标识
DOI:10.4155/fmc-2022-0008
摘要

Future Medicinal ChemistryVol. 14, No. 9 EditorialHIV-1 capsid inhibitors: a sword to destroy the virusXujie Zhang, Shujing Xu, Lin Sun, Dang Ding, Yucen Tao, Dongwei Kang, Xinyong Liu & Peng ZhanXujie Zhang https://orcid.org/0000-0003-1393-4665Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Shujing Xu https://orcid.org/0000-0002-7168-613XDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Lin SunDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Dang DingDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Yucen TaoDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Dongwei KangDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China, Xinyong Liu*Author for correspondence: E-mail Address: xinyongl@sdu.edu.cnDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR China & Peng Zhan**Author for correspondence: E-mail Address: zhanpeng1982@sdu.edu.cnDepartment of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, 250012, Jinan, Shandong, PR ChinaPublished Online:17 Mar 2022https://doi.org/10.4155/fmc-2022-0008AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleAbstractKeywords: capsid inhibitorHIV-1lenacapavirphenylalanine derivativesprotein–protein interactionReferences1. Zhang X, Sun L, Meuser ME et al. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors. Eur. J. Med. Chem. 226, 113848 (2021).Crossref, Medline, CAS, Google Scholar2. Zila V, Müller TG, Müller B, Kräusslich HG. HIV-1 capsid is the key orchestrator of early viral replication. PLoS Pathog. 17(12), e1010109 (2021).Crossref, Medline, CAS, Google Scholar3. Le Sage V, Mouland AJ, Valiente-Echeverría F. Roles of HIV-1 capsid in viral replication and immune evasion. Virus Res. 193, 116–129 (2014).Crossref, Medline, Google Scholar4. Campbell EM, Hope TJ. HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat. Rev. Microbiol. 13(8), 471–483 (2015).Crossref, Medline, CAS, Google Scholar5. Sun L, Zhang X, Xu S et al. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors. Eur. J. Med. Chem. 217, 113380 (2021).Crossref, Medline, CAS, Google Scholar6. Blair WS, Pickford C, Irving SL et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 6(12), e1001220 (2010).Crossref, Medline, Google Scholar7. Saito A, Ferhadian D, Sowd GA et al. Roles of capsid-interacting host factors in multimodal inhibition of HIV-1 by PF74. J. Virol. 90(12), 5808–5823 (2016).Crossref, Medline, CAS, Google Scholar8. Yant SR, Mulato A, Hansen D et al. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat. Med. 25(9), 1377–1384 (2019).Crossref, Medline, CAS, Google Scholar9. Vidal SJ, Bekerman E, Hansen D et al. Long acting capsid inhibitor protects macaques from repeat SHIV challenges. Nature (2021).Google Scholar10. Link JO, Rhee MS, Tse WC et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature 584(7822), 614–618 (2020).Crossref, Medline, CAS, Google Scholar11. Bester SM, Wei G, Zhao H et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science 370(6514), 360–364 (2020).Crossref, Medline, CAS, Google Scholar12. Christensen DE, Ganser-Pornillos BK, Johnson JS et al. Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science 370(6513), eabc8420 (2020).Crossref, Medline, CAS, Google Scholar13. Singh K, Gallazzi F, Hill KJ et al. GS-CA compounds: first-in-class HIV-1 capsid inhibitors covering multiple grounds. Front. Microbiol. 10, 1227 (2019).Crossref, Medline, Google Scholar14. Margot N, Ram R, Rhee M, Callebaut C. Absence of lenacapavir (GS-6207) phenotypic resistance in HIV gag cleavage site mutants and in isolates with resistance to existing drug classes. Antimicrob. Agents Chemother. 65(3), (2021).Crossref, Medline, Google Scholar15. Sun L, Dick A, Meuser ME et al. Design, synthesis, and mechanism study of benzenesulfonamide-containing phenylalanine derivatives as novel HIV-1 capsid inhibitors with improved antiviral activities. J. Med. Chem. 63(9), 4790–4810 (2020).Crossref, Medline, CAS, Google Scholar16. Meuser ME, Reddy PaN, Dick A et al. Rapid optimization of the metabolic stability of a human immunodeficiency virus type-1 capsid inhibitor using a multistep computational workflow. J. Med. Chem. 64(7), 3747–3766 (2021).Crossref, Medline, CAS, Google Scholar17. Sahani RL, Diana-Rivero R, Vernekar SKV et al. Design, synthesis and characterization of HIV-1 CA-targeting small molecules: conformational restriction of PF74. Viruses 13(3), 479 (2021).Crossref, Medline, CAS, Google Scholar18. Chia T, Nakamura T, Amano M et al. A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsid. Antimicrob. Agents Chemother. 65(10), e0103921 (2021).Crossref, Medline, Google Scholar19. Xu S, Sun L, Huang B, Liu X, Zhan P. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment. Future Med. Chem. 12(14), 1281–1284 (2020).Link, CAS, Google Scholar20. Ma Y, Frutos-Beltrán E, Kang D et al. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem. Soc. Rev. 50(7), 4514–4540 (2021).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByThe discovery and design of novel HIV-1 capsid modulators and future perspectives15 December 2022 | Expert Opinion on Drug Discovery, Vol. 18, No. 1Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators7 November 2022 | Molecules, Vol. 27, No. 21Metabolite Identification of HIV-1 Capsid Modulators PF74 and 11L in Human Liver Microsomes16 August 2022 | Metabolites, Vol. 12, No. 8 Vol. 14, No. 9 Follow us on social media for the latest updates Metrics Downloaded 101 times History Received 13 January 2022 Accepted 24 February 2022 Published online 17 March 2022 Published in print May 2022 Information© 2022 Newlands PressKeywordscapsid inhibitorHIV-1lenacapavirphenylalanine derivativesprotein–protein interactionFinancial & competing interests disclosureThe authors gratefully acknowledge financial support from National Natural Science Foundation of China (NSFC nos. 82173677, 81773574), Science Foundation for Outstanding Young Scholars of Shandong Province (no. ZR2020JQ31), the Foreign cultural and educational experts Project (no. GXL20200015001), the Shandong Provincial Key research and development project (no. 2019JZZY021011), Chang Jiang Scholars Program of Ministry of Education, People's Republic of China (no. 2021108), Taishan Scholar Program at Shandong Province, Qilu Young Scholars Program of Shandong University. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LEI发布了新的文献求助10
刚刚
繁星完成签到,获得积分10
1秒前
畅快的雅青完成签到,获得积分10
2秒前
JY'完成签到,获得积分0
2秒前
柯柯完成签到 ,获得积分10
2秒前
英俊马里奥完成签到,获得积分10
2秒前
康康完成签到,获得积分10
3秒前
brick2024完成签到,获得积分10
3秒前
liyiren完成签到,获得积分10
3秒前
踏实月亮完成签到,获得积分10
3秒前
天舞英姿完成签到,获得积分10
3秒前
Ray完成签到 ,获得积分10
3秒前
David完成签到,获得积分10
3秒前
czzlancer完成签到,获得积分10
4秒前
王海海完成签到 ,获得积分10
4秒前
星辰完成签到,获得积分10
4秒前
张青见完成签到,获得积分10
5秒前
5秒前
江南烟雨如笙完成签到 ,获得积分10
5秒前
研友_ngqjz8完成签到,获得积分10
5秒前
luan完成签到,获得积分10
6秒前
KMGTmunp完成签到,获得积分10
7秒前
丘比特应助天舞英姿采纳,获得10
8秒前
酷波er应助执着念寒采纳,获得10
8秒前
8秒前
爆米花应助lsj2233采纳,获得10
9秒前
狂野白梅完成签到,获得积分10
9秒前
9秒前
winnie完成签到,获得积分20
9秒前
YeeLeeLee完成签到,获得积分10
10秒前
黑摄会阿Fay完成签到,获得积分10
10秒前
远看寒山完成签到,获得积分10
10秒前
顺心从安完成签到,获得积分10
10秒前
gracelilili完成签到 ,获得积分10
10秒前
cy发布了新的文献求助10
11秒前
11秒前
刘稀完成签到,获得积分10
11秒前
呆鸥完成签到,获得积分10
11秒前
自由饼干完成签到,获得积分10
12秒前
iron完成签到,获得积分20
12秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Very-high-order BVD Schemes Using β-variable THINC Method 870
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Fundamentals of Dispersed Multiphase Flows 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3253292
求助须知:如何正确求助?哪些是违规求助? 2895780
关于积分的说明 8288340
捐赠科研通 2564687
什么是DOI,文献DOI怎么找? 1392497
科研通“疑难数据库(出版商)”最低求助积分说明 652220
邀请新用户注册赠送积分活动 629453